
What Biden’s Drug Price Negotiations Mean for You
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
Ten medications, costing tens of billions of dollars, will be the first to be subject to Medicare price negotiations
Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability
Experts are more concerned about a lack of activity in older adults who are somewhat overweight than about weight loss
A federal rule would require companies to disclose whether their products contain chemicals known as PFASs
States will get less funding for childhood vaccines, a move linked to the recent debt ceiling deal
Many generic drugs for cancer and ADHD, blood thinners and antibiotics are in short supply, in part because there is little profit in making them
Many physicians say they are reluctant to practice in states with abortion bans, harming access to regular exams and screenings
Criminalizing patients could have adverse consequences, experts warn
After the Supreme Court overturned Roe v. Wade, physical and legal attacks against clinics that provide abortions have increased
A federal judge’s ruling that invalidates part of the Affordable Care Act could mean people will have to pay for certain types of preventive care, though likely not immediately
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account